Muhammad Ajmal

Muhammad Ajmal practices at The Jewish Hospital - Mercy Health in Cincinnati, Ohio, part of Bon Secours Mercy Health.

Muhammad Ajmal's NPI, 1639552433, was assigned on June 30, 2015. Muhammad Ajmal graduated from King Edward Medical University in 2012. Muhammad Ajmal's Illinois license number on file is 125066964.

Muhammad Ajmal's primary practice is The Jewish Hospital - Mercy Health, at 4777 East Galbraith Road, Cincinnati, OH 45236 in Hamilton County. The practice phone is (513) 686-3000.

Muhammad Ajmal's primary practice is The Jewish Hospital - Mercy Health in Cincinnati, Ohio, part of Bon Secours Mercy Health. Muhammad Ajmal is also affiliated with Mercy Health - West Hospital. The medical group on file is Mercy Health Physicians. Dmand AI also links Muhammad Ajmal to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Muhammad Ajmal practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Muhammad Ajmal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Muhammad Ajmal is board certified in certified american board of nuclear cardiology by the Alliance for Physician Certification and Advancement. Dmand AI has Muhammad Ajmal's licenses on file in 3 states: Illinois, Iowa and Arizona.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy and cerebrovascular disease among the conditions Muhammad Ajmal treats.

CMS data shows 5,127 Medicare services from Muhammad Ajmal across 26 procedure codes in 2024, for 2,456 Medicare patients. Medicare paid $199,953 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 2,456 Medicare patients who saw Muhammad Ajmal in 2024. The largest group is 65 to 74, with 921 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Muhammad Ajmal's median patient age at 72, with 50% women.

In 2024, Muhammad Ajmal wrote 5,105 Medicare Part D claims for 670 patients. 86% of them were for generic drugs. CMS names the drug for 4,968 of them, across 49 drugs with 11 or more claims each, at $627,471 in total drug cost. In 2023, CMS named 2,754 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Muhammad Ajmal for performance year 2024, reported as part of a group. Muhammad Ajmal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 44 procedures of coronary angioplasty and stenting by Muhammad Ajmal, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 24 papers to Muhammad Ajmal, published from 2017 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Anticoagulants, Atrial Fibrillation and Atrial Appendage. Muhammad Ajmal has published most often in Am J Med. Muhammad Ajmal's most frequent co-authors are Ranjith Shetty, MD, Cristina Pecci, DO and Tushar Acharya, MD.

CMS Open Payments shows 40 general payments to Muhammad Ajmal from 18 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 60% of the total. Terumo Medical Corporation paid the most, $897.

Dmand AI lists 9 awards for Muhammad Ajmal, most recently Excellence in clinical practice in 2025.

Muhammad Ajmal graduated from King Edward Medical University in 2012. Muhammad Ajmal is a member of ACC.

Muhammad Ajmal is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.